Login to Your Account



Financings Roundup

Synageva Upsizes Again and Seeks $100M in Public Offering

By Marie Powers
Staff Writer

Monday, January 7, 2013
Synageva BioPharma Corp. took advantage of a 2 percent increase in its stock price during the New Year and bumped up the number of shares to boost the size of its public offering by 25 percent, from approximately 1.7 million shares cited in a preliminary prospectus supplement filed Thursday with the SEC to 2.15 million shares at Thursday's closing price of $47.53.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription